Division of Infectious Diseases, Department of Pediatrics, New York University School of Medicine, New York, New York, USA.
Bomu Hospital, Mombasa, Kenya.
J Infect Dis. 2021 Nov 22;224(10):1785-1795. doi: 10.1093/infdis/jiab204.
PD-1 marks exhausted T cells, with weak effector functions. Adults living with human immunodeficiency virus (HIV) have increased levels of PD-1+ CD8 T cells that correlate with HIV disease progression, yet little is known about the role of PD-1+ CD8 T cells in children with perinatal HIV.
We enrolled 76 Kenyan children with perinatal HIV and 43 children who were HIV unexposed and quantified PD-1 levels on CD8 T cells; their coexpression with immune checkpoints (ICs) 2B4, CD160, and TIM3; correlates with immune activation and HIV disease progression; and HIV-specific and -nonspecific proliferative responses.
PD-1+ CD8 T-cell frequencies are elevated in children with perinatal HIV and associated with disease progression. The majority of PD-1+ CD8 T cells coexpress additional ICs. ART initiation lowers total PD-1 levels and coexpression of multiple ICs. The frequency of PD-1+2B4+CD160+TIM3- in PD-1+ CD8 T cells predicts weaker HIV-specific proliferative responses, suggesting that this subset is functionally exhausted.
Children with perinatal HIV have high levels of PD-1+ CD8 T cells that are a heterogeneous population differentially coexpressing multiple ICs. Understanding the complex interplay of ICs is essential to guide the development of PD-1-directed immunotherapies for pediatric HIV remission and cure.
PD-1 标记衰竭的 T 细胞,其效应功能较弱。患有人类免疫缺陷病毒 (HIV) 的成年人中 PD-1+CD8 T 细胞水平升高,与 HIV 疾病进展相关,但对于围产期 HIV 儿童中 PD-1+CD8 T 细胞的作用知之甚少。
我们招募了 76 名肯尼亚围产期 HIV 儿童和 43 名未感染 HIV 的儿童,并对 CD8 T 细胞上的 PD-1 水平进行了定量;它们与免疫检查点(ICs)2B4、CD160 和 TIM3 的共表达;与免疫激活和 HIV 疾病进展相关;以及 HIV 特异性和非特异性增殖反应。
围产期 HIV 儿童中 PD-1+CD8 T 细胞频率升高,并与疾病进展相关。大多数 PD-1+CD8 T 细胞共表达其他 ICs。ART 启动降低总 PD-1 水平和多种 IC 的共表达。PD-1+2B4+CD160+TIM3-在 PD-1+CD8 T 细胞中的频率预测 HIV 特异性增殖反应较弱,表明该亚群功能衰竭。
围产期 HIV 儿童存在高水平的 PD-1+CD8 T 细胞,这些细胞是一个异质性群体,不同程度地共表达多种 IC。了解 IC 之间的复杂相互作用对于指导针对儿童 HIV 缓解和治愈的 PD-1 导向免疫疗法的发展至关重要。